Browsing by Author van Nieuwenhuijzen, Pieternel (Petra)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2017The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptorsArnold, Jonathon; Bakas, Timothy; Collins, Mary; Devenish, Steven; McGregor, Iain; van Nieuwenhuijzen, Pieternel (Petra); School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; Pharmacy; Pharmacy; Psychology; PharmacyThe direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors, Pharmacological Research, vol.119, N/A, 2017,pp 358-370
2013Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons.Ahmed, Eakhlas; Ahmed, Selina; Karanges, Emily; Kashem, Mohammed; Kemp, Andrew; McGregor, Iain; Sarker, Ranjana; van Nieuwenhuijzen, Pieternel (Petra); Psychology; Psychology; Psychology; Psychology; Psychology; Psychology; Psychology; PharmacyHippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons., Frontiers in Pharmacology, vol.4, N/A, 2013,pp 1-13
2016A pharmacological characterization of GABA, THIP and DS2 at binary alpha4Beta3 and Beta3delta receptors: GABA activates Beta3delta receptors via the Beta3(+)delta(-) interfaceAbsalom, Nathan Luke; Ahring, Joergen Phillip; Collins, Mary; Hanrahan, Jane; Lee, Ho Joon; van Nieuwenhuijzen, Pieternel (Petra); Pharmacy; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyA pharmacological characterization of GABA, THIP and DS2 at binary alpha4Beta3 and Beta3delta receptors: GABA activates Beta3delta receptors via the Beta3(+)delta(-) interface, Brain Research, vol.1644, N/A, 2016,pp 222-230
2016A pharmacological characterization of GABA, THIP and DS2 at binary alpha4Beta3 and Beta3delta receptors: GABA activates Beta3delta receptors via the Beta3(+)delta(-) interfaceAbsalom, Nathan Luke; Ahring, Joergen Phillip; Collins, Mary; Hanrahan, Jane; Lee, Ho Joon; van Nieuwenhuijzen, Pieternel (Petra); Pharmacy; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyA pharmacological characterization of GABA, THIP and DS2 at binary alpha4Beta3 and Beta3delta receptors: GABA activates Beta3delta receptors via the Beta3(+)delta(-) interface, Brain Research, vol.1644, N/A, 2016,pp 222-230
2014Regional Fos-expression induced by γ-hydroxybutyrate (GHB): Comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382Chebib, Mary; Hunt, Glenn; McGregor, Iain; van Nieuwenhuijzen, Pieternel (Petra); Pharmacy; Concord Clinical School: Psychological Medicine; Psychology; PharmacyRegional Fos-expression induced by γ-hydroxybutyrate (GHB): Comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382, Neuroscience, vol.277, N/A, 2014,pp 700-715
2016Zolpidem is a potent stoichiometry-selective modulator of (alpha)1(beta)3 GABAA receptors: evidence of a novel benzodiazepine site in the (alpha)1-(alpha)1 interfaceAbsalom, Nathan Luke; Ahring, Joergen Phillip; Che Has, Ahmad; Clarkson, Andrew; Collins, Mary; van Nieuwenhuijzen, Pieternel (Petra); Pharmacy; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyZolpidem is a potent stoichiometry-selective modulator of (alpha)1(beta)3 GABAA receptors: evidence of a novel benzodiazepine site in the (alpha)1-(alpha)1 interface, Scientific Reports, vol.6, N/A, 2016,pp 1-12
2016Zolpidem is a potent stoichiometry-selective modulator of (alpha)1(beta)3 GABAA receptors: evidence of a novel benzodiazepine site in the (alpha)1-(alpha)1 interfaceAbsalom, Nathan Luke; Ahring, Joergen Phillip; Che Has, Ahmad; Clarkson, Andrew; Collins, Mary; van Nieuwenhuijzen, Pieternel (Petra); Pharmacy; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyZolpidem is a potent stoichiometry-selective modulator of (alpha)1(beta)3 GABAA receptors: evidence of a novel benzodiazepine site in the (alpha)1-(alpha)1 interface, Scientific Reports, vol.6, N/A, 2016,pp 1-12